
 [
{
"symbol" : "506820",
"exchange" : "BOM",
"id": "676964",
"t" : "506820",
"e" : "BOM",
"name" : "Astrazeneca Pharma India Ltd"
, "f_reuters_url" : "http:\u002F\u002Fstocks.us.reuters.com\u002Fstocks\u002Fratios.asp?rpc=66\u0026symbol=",
"f_recent_quarter_date" : "",
"f_annual_date" : "",
"f_ttm_date" : "",
"financials" :
[{
"f_type" : "Income\u0026nbsp\u003BStatement"
,"url" : "http:www.google.comfinance?fstype=ii&q=BOM:506820"
,"f_figures" :
[
]
},
{
"f_type" : "Balance\u0026nbsp\u003BSheet"
,"url" : "http:www.google.comfinance?fstype=bi&q=BOM:506820"
,"f_figures" :
[
]
},
{
"f_type" : "Cash\u0026nbsp\u003BFlow"
,"url" : "http:www.google.comfinance?fstype=ci&q=BOM:506820"
,"f_figures" :
[
]
}],
"kr_recent_quarter_date" : "Q4 (Dec \u002717)",
"kr_annual_date" : "2017",
"kr_ttm_date" : "TTM",
"keyratios" :
[
{
"title" : "Net profit margin",
"recent_quarter" : "-8.05%",
"annual" : "4.53%",
"ttm" : "3.72%"
},
{
"title" : "Operating margin",
"recent_quarter" : "-11.34%",
"annual" : "3.51%",
"ttm" : "2.14%"
},
{
"title" : "EBITD margin",
"recent_quarter" : "",
"annual" : "6.44%",
"ttm" : "4.93%"
},
{
"title" : "Return on average assets",
"recent_quarter" : "",
"annual" : "6.26%",
"ttm" : ""
},
{
"title" : "Return on average equity",
"recent_quarter" : "",
"annual" : "14.53%",
"ttm" : ""
},
{
"title" : "Employees",
"recent_quarter" : "1,141",
"annual" : "-",
"ttm" : "-"
}
]
, "c" : "-7.15",
"l" : "1,016.00",
"cp" : "-0.70",
"ccol" : "chr",
"op" : "1,035.00",
"hi" : "1,036.45",
"lo" : "1,013.30",
"vo" : "904.00",
"avvo" : "",
"hi52" : "1,278.00",
"lo52" : "882.55",
"mc" : "25.63B",
"pe" : "128.15",
"fwpe" : "",
"beta" : "",
"eps" : "7.93",
"dy" : "",
"ldiv" : "",
"shares" : "25.00M",
"instown" : "",
"eo":""
, "related" : [
{
"id" : "676964",
"name" : "Astrazeneca Pharma India Ltd",
"t" : "506820",
"e" : "BOM",
"l" : "1,016.00",
"c" : "-7.15",
"mc" : "25.63B",
"cp" : "-0.70",
"ccol" : "chr"
}
,
{
"id" : "6521463",
"name" : "Parenteral Drugs (India) Ltd.",
"t" : "PDPL",
"e" : "NSE",
"l" : "18.60",
"c" : "-0.15",
"mc" : "554.58M",
"cp" : "-0.80",
"ccol" : "chr"
}
,
{
"id" : "3630125",
"name" : "Zyden Gentec Ltd",
"t" : "530091",
"e" : "BOM",
"l" : "0.87",
"c" : "0.00",
"mc" : "49.00M",
"cp" : "0.00",
"ccol" : "chb"
}
,
{
"id" : "3900000",
"name" : "Smruthi Organics Ltd",
"t" : "540686",
"e" : "BOM",
"l" : "111.70",
"c" : "-2.80",
"mc" : "426.18M",
"cp" : "-2.45",
"ccol" : "chr"
}
,
{
"id" : "3678877",
"name" : "Jagsonpal Pharmaceuticals Ltd",
"t" : "JAGSNPHARM",
"e" : "NSE",
"l" : "32.55",
"c" : "+0.35",
"mc" : "854.07M",
"cp" : "1.09",
"ccol" : "chg"
}
,
{
"id" : "8321085",
"name" : "Godavari Drugs Ltd",
"t" : "530317",
"e" : "BOM",
"l" : "35.65",
"c" : "+1.65",
"mc" : "268.46M",
"cp" : "4.85",
"ccol" : "chg"
}
,
{
"id" : "4807790",
"name" : "Jupiter Bioscience Ltd",
"t" : "JUPITER",
"e" : "NSE",
"l" : "6.95",
"c" : "0.00",
"mc" : "433.91M",
"cp" : "0.00",
"ccol" : "chb"
}
,
{
"id" : "12622704",
"name" : "Patidar Buildcon Ltd",
"t" : "524031",
"e" : "BOM",
"l" : "7.03",
"c" : "0.00",
"mc" : "38.67M",
"cp" : "0.00",
"ccol" : "chb"
}
,
{
"id" : "5262084",
"name" : "Marksans Pharma Limited",
"t" : "MARKSANS",
"e" : "NSE",
"l" : "38.60",
"c" : "-0.20",
"mc" : "15.74B",
"cp" : "-0.52",
"ccol" : "chr"
}
,
{
"id" : "10147154",
"name" : "Natco Pharma Ltd.",
"t" : "NATCOPHARM",
"e" : "NSE",
"l" : "775.00",
"c" : "-3.15",
"mc" : "143.19B",
"cp" : "-0.40",
"ccol" : "chr"
}
,
{
"id" : "805988453466693",
"name" : "Sakar Healthcare Ltd",
"c" : "",
"mc" : "",
"cp" : "",
"ccol" : ""
}
]
, "summary" : [{
"address": "Ni 12Th Floor, Manyata Empassy Business Park Rachenahalli,Outer Ring Rd Kr Puram Hebbal, BANGALORE, 560045, India",
"phone": "+91-80-67748000",
"fax": "+91-80-23622015",
"url": "https:\u002F\u002Fwww.astrazeneca.com\u002Fcountry-sites\u002Findia.html",
"overview" : "AstraZeneca Pharma India Limited is a global biopharmaceutical company. The Company is engaged in the discovery, development and commercialization of medicines for core areas of healthcare, including cardiovascular\u002Fmetabolic disease, cancer and respiratory, inflammatory and autoimmune disease. The Company operates through two segments: Healthcare and Clinical Trial. The Healthcare segment engages in the manufacture and sale of pharmaceutical products. The Clinical Trial segment renders clinical trial services on pharmaceutical products to its group companies. It has presence in over seven areas of healthcare, including diabetes, oncology, infection, local anesthesia and maternal healthcare. The principal products\u002Fservices of the Company are Meronem and Brilinta\u002FAxcer. Its pipeline includes products, such as AZD4076, MEDI6012, AZD2811, MEDI0680, selumetinib, anifrolumab and MEDI7510. Its brands include Crestor, Seloken XL, Meronem, Arimidex, Zoladex, Nexium and Brilinta."
} ]
, "management" : [
{
"name" : "Rajesh Marwaha",
"age" : "54",
"title" : "Chief Financial Officer, Acting Compliance Officer, Whole Time Director"
}
,
{
"name" : "Pratap Rudra",
"title" : "Compliance Officer, Company Secretary"
}
,
{
"name" : "Gagan Singh Bedi",
"age" : "45",
"title" : "Managing Director, Director"
}
,
{
"name" : "Sanjay Murdeshwar",
"age" : "48",
"title" : "Managing Director, Director"
}
,
{
"name" : "Darius Erach Udwadia Esq.",
"age" : "76",
"title" : "Non-Executive Independent Chairman of the Board"
}
,
{
"name" : "Claire-Marie O\u0027Grady",
"title" : "Director"
}
,
{
"name" : "Ian Brimicombe",
"age" : "51",
"title" : "Non-Executive Director"
}
,
{
"name" : "Gegory David Emil Mueller",
"age" : "46",
"title" : "Non-Executive Director"
}
,
{
"name" : "Ian John Parish",
"age" : "45",
"title" : "Non-Executive Director"
}
]
,"moreresources" : [
]
}]
